To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2016

Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients

Vol: 5| Issue: 6| Number:6| ISSN#: 2564-2537
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A

The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials

Osteoporos Int. 2016 Jan;27(1):295-9

Contributing Authors:
HF Yuan CA Guo ZQ Yan

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

5 randomized controlled trials investigating the benefits of bisphosphonate therapy in the treatment of femoral head osteonecrosis were included in this meta-analysis. The purpose of this study was to determine whether bisphosphonate treatment should be recommended to patients suffering from this condition. The findings of this report indicated that bisphosphonates did not reduce the progression t...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.